Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Are Beneficial in Normotensive Atherosclerotic Patients: A Collaborative Meta-Analysis of Randomized Trials

Study Questions:

Are angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin-receptor blockers (ARBs) beneficial in individuals with, or at increased risk for, atherosclerotic vascular disease who are normotensive?